Kantar Health appoints Richard Goosey as UK senior director
pharmafile | April 20, 2012 | Appointment | Business Services, Medical Communications, Sales and Marketing | Kantar Health, Richard Goosey, Roche
Consultancy and marketing insights company Kantar Health has appointed Richard Goosey as UK senior director of Advanced Methods.
Goosey has 30 years of consultancy experience in marketing sciences and advanced analytics on both the agency and client side, covering both healthcare and consumer markets.
Goosey joins Kantar Health from Roche UK, where he specialised in business planning and forecasting in support of the Oncology HER2 Franchise.
Prior to Roche he was head of Business Intelligence and Commercial Planning for Lundbeck, specialising in psychiatry and neurology, where he provided business support services across the brand portfolio.
“We are delighted to welcome Richard into the Kantar Health family,” says Jim Needell, managing director, UK. “His vast experience in designing complex studies and consulting with senior clients continues our evolution as a business to better meet the changing needs of our clients.”
Related Content

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …






